Editors in Conversation
Ein Podcast von American Society for Microbiology
91 Folgen
-
The Global Antibiotic Research & Development Partnership (GARDP)
Vom: 13.12.2024 -
At-Home Collection and Testing for STIs
Vom: 11.11.2024 -
High Level Meeting on AMR at the United Nations: A Debrief
Vom: 26.10.2024 -
The Launch of ASM Case Reports Journal
Vom: 11.10.2024 -
Heteroresistance: Mechanisms, Diagnosis and Clinical Implications
Vom: 13.9.2024 -
Microbiology in the Headlines: H5N1 in Dairy Cattle, The Plague, Measles, Neosporin and more!
Vom: 16.8.2024 -
The Global Preclinical Antibacterial Pipeline
Vom: 26.7.2024 -
Turning the Output of the Microbiology Laboratory Into Gold
Vom: 28.6.2024 -
Training in Antimicrobial Resistance: Gaps and Opportunities
Vom: 1.6.2024 -
10 Years of Rhodococcus: Clinical Trends and Susceptibility Profiles
Vom: 19.4.2024 -
Why Phage Therapy May Fail
Vom: 5.4.2024 -
Is Lophomonas a Pathogen?
Vom: 23.2.2024 -
Treatment of Multidrug-resistant Tuberculosis
Vom: 9.2.2024 -
New generation B-lactam/B-lactamase inhibitors: Taniborbactam
Vom: 13.1.2024 -
Favorite Clinical Microbiology Papers of 2023 (JCM ed.)
Vom: 23.12.2023 -
Antimicrobial Resistance in Neisseria Gonorrhoeae (JCM ed.)
Vom: 5.12.2023 -
New Antifungals (AAC ed.)
Vom: 10.11.2023 -
A Novel Coccidioides Antibody LFA (JCM ed.)
Vom: 20.10.2023 -
Climate Change and Antimicrobial Resistance (AAC ed.)
Vom: 7.10.2023 -
Emerging Antifungal-Resistant Dermatophytes (JCM ed.)
Vom: 22.9.2023
Editors in Conversation is the official podcast of the American Society for Microbiology Journals. Editors in Conversation features discussions between ASM Journals Editors, researchers and clinicians working on the most cutting edge issues in the microbial sciences. Topics include laboratory diagnosis and clinical treatment of infectious diseases, antimicrobial resistance, epidemiology of infections, multidrug-resistant organisms, pharmacology of antimicrobial agents, susceptibility testing, and more. The podcast is directed to microbiologists, infectious diseases clinicians, pharmacists and basic, clinical and translational researchers interested in the microbial sciences. A particular emphasis is on basic, epidemiological and pharmacological aspects of infectious diseases, including antimicrobial resistance and therapeutics.
